Genedrive Plc products

Our newest Genedrive^® System, incorporating a number of user-led improvements to our small patented gene amplification technology platform, for ease of use in time critical situations and to simplify workflow for our customers. The new System is targeted for professional use in emergency healthcare settings, and will be introduced to support the launch of Genedrive`s new Antibiotic Induced Hearing Loss test. Streamlined data management - RFID enabled reagent lock out to prevent the use of expired kits. Simple usability - fail safe physical solutions added to improve usability and prevent test failure through premature cartridge removal. New intuitive user interface - 7" integrated touch screen for more flexible user interaction. Improved communication capability - new wireless connectivity and printer options. All provided in one compact, benchtop system for rapid, near patient molecular testing in an emergency care setting.

Genedrive^® is a low-cost, rapid, simple-to-use device that brings molecular diagnostics closer to the patient. The Genedrive® instrument is an automated molecular diagnostic platform used to detect and discriminate nucleic acid signatures for a variety of applications including infectious disease and pathogen detection. The device utilises a number of different sample types including buccal swabs, plasma and nasal swabs.

World’s first point of care genetic test used to influence neonatal management in an acute setting and reduce aminoglycoside induced hearing loss, Prevention - reduces the likelihood of aminoglycoside induced hearing loss, Rapid results - point-of-care genetic test yields results in 30 minutes, Simple to use - by healthcare professionals with minimal training.

7.5 minute1 point of care molecular testing now possible with the NEW CE marked Genedrive® COV19-ID Kit